Liposomal Mitoxantrone Hydrochloride Injection,Cyclophosphamide, Vincristine and Prednisone in the Treatment of PTCL
Status:
Recruiting
Trial end date:
2023-10-15
Target enrollment:
Participant gender:
Summary
This is a multicentre, open-label, single-arm, phase Ib clinical study to evaluate the
safety, tolerability, efficacy and pharmacokinetics of liposomal mitoxantrone hydrochloride
in combination with Cyclophosphamide, Vincristine and Prednisone in the frontline treatment
of patients with peripheral T cell lymphoma (PTCL).